FindTrial
Sign In

The effect of preimplantation genetic screening 2.0 on the outcome of assisted reproductive treatment in patients with unexplained recurrent pregnancy loss: a multicenter, prospective, randomized controlled trial

The effect of preimplantation genetic screening 2.0 on the outcome of assisted reproductive treatment in patients with unexplained recurrent pregnancy loss: a multicenter, prospective, randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014790
Enrollment
Unknown
Registered
2018-02-05
Start date
2018-02-06
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent pregnancy loss

Interventions

PGS group:PGS
non-PGS group:conventional embryo morphology evaluation

Sponsors

Shanghai Ji Ai Genetics & IVF Institute, Obstetrics and Gynecology Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1. The couple has experienced two or more failed pregnancies (according to ASRM definition); 2. The karyotypes of both husband and wife are normal (polymorphic chromosomes are considered normal either); 3. Women ages =20 and <38 years old.

Exclusion criteria

Exclusion criteria: The wife has a medical condition that contraindicate asissted invitro fertilization or pregnancy.

Design outcomes

Primary

MeasureTime frame
live birthe rate;—

Secondary

MeasureTime frame
ongoing pregnancy rate;—

Countries

China

Contacts

Public ContactSun Xiaoxi

Shanghai Ji Ai Genetics & IVF Institute, Obstetrics and Gynecology Hospital, Fudan University

xiaoxi_sun@aliyun.com+86 13671992979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026